Nephroscience
K-smatco Lifesciences began its journey in 2012, concentrating on the chronic therapeutic area of Nephrology. We pioneered addressing the needs of early-stage Chronic Kidney Disease (CKD) patients, a daunting task, particularly in India, where over 20 million individuals are estimated to have some form of kidney disease, yet merely around 1% (approximately 200,000 to 250,000) are diagnosed or receiving renal treatment.
Despite these challenges, K-smatco Lifesciences has quickly positioned itself as a leader in Nephrology, providing care to the largest number of CKD patients in India. Our commitment to delivering high-quality, innovative treatments has allowed us to become a trusted partner in the healthcare journey of CKD patients nationwide.
